Avicenna Biosciences
Avicenna Biosciences, Inc. is a biotechnology company focused on accelerating drug discovery through its ML-driven medicinal chemistry platform. The company specializes in Lead Optimization, addressing common issues in drug development such as off-target toxicity and poor pharmacokinetics. Avicenna's proprietary methods allow for rapid identification of new chemical entities, significantly reducing synthetic effort and time to market. Their notable achievements include the development of orally available, CNS-penetrant ROCK inhibitors for neurodegenerative diseases, showcasing their competitive edge in the crowded bioscience ecosystem. Collaborating with pharmaceutical and biotechnology companies, Avicenna aims to optimize drug development campaigns and enhance the risk-return profile for their partners.
Avicenna Biosciences
Avicenna Biosciences, Inc. is a biotechnology company focused on accelerating drug discovery through its ML-driven medicinal chemistry platform. The company specializes in Lead Optimization, addressing common issues in drug development such as off-target toxicity and poor pharmacokinetics. Avicenna's proprietary methods allow for rapid identification of new chemical entities, significantly reducing synthetic effort and time to market. Their notable achievements include the development of orally available, CNS-penetrant ROCK inhibitors for neurodegenerative diseases, showcasing their competitive edge in the crowded bioscience ecosystem. Collaborating with pharmaceutical and biotechnology companies, Avicenna aims to optimize drug development campaigns and enhance the risk-return profile for their partners.